Effects of Levosimendan Versus Dobutamine on Inflammatory and Apoptotic Pathways in Acutely Decompensated Chronic Heart Failure

This publication has 15 references indexed in Scilit:

• Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
  European Heart Journal, 2005
• Attenuation of NF-?B signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes
  Cardiovascular Research, 2004
• Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure
  The American Journal of Cardiology, 2004
• The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts
  Intensive Care Medicine, 2003
• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
  The Lancet, 2002
• A glossary of circulating cytokines in chronic heart failure
  European Journal of Heart Failure, 2001
• Mechanisms and Models in Heart Failure
  Circulation, 1999
• Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis
  Journal of the American College of Cardiology, 1999
• Basic Mechanisms in Congestive Heart Failure
  Chest, 1994
• Relation of left ventricular shape, function and wall stress in man
  The American Journal of Cardiology, 1974